DK114553B - Fremgangsmåde til fremstilling af biologisk aktive 7α-methyl-3-keto-Δ<5(10)>-østrener. - Google Patents

Fremgangsmåde til fremstilling af biologisk aktive 7α-methyl-3-keto-Δ<5(10)>-østrener.

Info

Publication number
DK114553B
DK114553B DK297965AA DK297965A DK114553B DK 114553 B DK114553 B DK 114553B DK 297965A A DK297965A A DK 297965AA DK 297965 A DK297965 A DK 297965A DK 114553 B DK114553 B DK 114553B
Authority
DK
Denmark
Prior art keywords
estrenes
keto
methyl
preparation
biologically active
Prior art date
Application number
DK297965AA
Other languages
Danish (da)
English (en)
Inventor
Jongh H De
Vliet N Van
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of DK114553B publication Critical patent/DK114553B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK297965AA 1964-06-16 1965-06-14 Fremgangsmåde til fremstilling af biologisk aktive 7α-methyl-3-keto-Δ<5(10)>-østrener. DK114553B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL646406797A NL146383B (nl) 1964-06-16 1964-06-16 Werkwijze ter bereiding van anabool werkzame 7alfa-methyl-steroiden van de oestraanreeks, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.

Publications (1)

Publication Number Publication Date
DK114553B true DK114553B (da) 1969-07-14

Family

ID=19790312

Family Applications (1)

Application Number Title Priority Date Filing Date
DK297965AA DK114553B (da) 1964-06-16 1965-06-14 Fremgangsmåde til fremstilling af biologisk aktive 7α-methyl-3-keto-Δ<5(10)>-østrener.

Country Status (10)

Country Link
US (1) US3340279A (pl)
BE (1) BE665514A (pl)
BR (1) BR6570429D0 (pl)
CH (1) CH517725A (pl)
DE (1) DE1543273C3 (pl)
DK (1) DK114553B (pl)
FR (1) FR1594513A (pl)
GB (1) GB1104462A (pl)
NL (1) NL146383B (pl)
SE (1) SE336788B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875188A (en) * 1968-04-10 1975-04-01 Eugene E Galantay 17-Beta-alpha-lower alkyl allene-substituted steroids
BE755689A (fr) * 1969-09-03 1971-03-03 Upjohn Co Procede de fabrication de nouvelles 7 beta-alkyl-19- nortestosterones
US3997664A (en) * 1971-02-09 1976-12-14 Sandoz, Inc. Substituted carbinol derivatives
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
DK1121375T3 (da) 1998-10-16 2003-08-04 Akzo Nobel Nv (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-on i høj renhedsgrad
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
KR20050038590A (ko) * 2003-05-23 2005-04-27 엔.브이. 오가논 다형성 티볼론을 포함하는 즉시-방출형 약학 제형
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
AU2017260799B2 (en) 2016-05-04 2022-11-24 Novalon S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2725389A (en) * 1953-08-31 1955-11-29 Searle & Co 13-methyl-17-ethynyl-17-hydroxy-1, 2, 3, 4, 6, 7, 8, 9, 11, 12, 13, 14, 16, 17-tetradecahydro15h-cyclopenta [a] phenanthren-3-one and its preparation
US3262949A (en) * 1956-11-13 1966-07-26 Syntex Corp 7-methyl androstane compounds
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process

Also Published As

Publication number Publication date
BE665514A (pl)
SE336788B (pl) 1971-07-19
DE1543273C3 (de) 1974-02-21
NL146383B (nl) 1975-07-15
DE1543273B2 (de) 1973-07-05
US3340279A (en) 1967-09-05
DE1543273A1 (de) 1969-08-07
BR6570429D0 (pt) 1973-08-14
GB1104462A (en) 1968-02-28
NL6406797A (pl) 1965-12-17
CH517725A (de) 1972-01-15
FR1594513A (pl) 1970-06-08

Similar Documents

Publication Publication Date Title
DK125553B (da) Fremgangsmåde til fremstilling af substituerede 2,4-diamino-5-benzylpyrimidiner.
DK111956B (da) Fremgangsmåde til fremstilling af 3,5-dioxo-17β-hydroxy-4,5-seco-Δ&lt;9&gt;-estren.
DK114553B (da) Fremgangsmåde til fremstilling af biologisk aktive 7α-methyl-3-keto-Δ&lt;5(10)&gt;-østrener.
DK123170B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 3-oxo-7α-methyl-Δ&lt;4,9,11&gt;-estratriener.
DK115547B (da) Fremgangsmåde til fremstilling af 17α-acyloxy-16-methyl-9α-flour-Δ&lt;1,4&gt;-pregnadien-3,20-dioner.
DK119107B (da) Fremgangsmåde til fremstilling af 11β-hydroperoxy-3-oxo-13-alkyl-Δ&lt;4,9&gt;-gonadiener.
DK104676C (da) Fremgangsmåde til fremstilling af N&lt;1&gt;-benzensulfonyl-N&lt;2&gt;-tetrahydrokinolino- eller -isokinolinourinstoffer.
DK112033B (da) Fremgangsmåde til fremstilling af 3-oxo-13β-alkyl-17β-hydroxy-17α-ethinylgona-5(10),9(11)-diener.
DK116294B (da) Analogifremgangsmåde til fremstilling af 4&#39;-demethyl-epipodophyllotoxin.
DK114273B (da) Fremgangsmåde til fremstilling af α-methyl-α-amino-β-(3,4-disubstituerede-phenyl)-propionitriler.
DK114267B (da) Fremgangsmåde til fremstilling af terapeutisk virksomme 17β-trialkylsiloxy-Δ&lt;4&gt;-androstener eller - estrener.
DK121510B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5(10)&gt;-østrener.
DK116658B (da) Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ&lt;5&gt;-østrener.
DK104301C (da) Fremgangsmåde til fremstilling af 3-hydroksy- eller 3-karbonhydridoksy-Δ&lt;1,3,5(10)&gt;-19-nor-steroider.
DK111487B (da) Fremgangsmåde til fremstilling af 17β-hydroxy- eller 17β-alkanoyloxy-3-keto-Δ&lt;4,8(14),9&gt;-gonatriener.
DK112031B (da) Fremgangsmåde til fremstilling af 3,20-dioxo-17α-methyl-19-nor-pregna-4,9,11-trien.
DK106090C (da) Fremgangsmåde til fremstilling af 3-halogen-Δ&lt;5&gt;-19-nor-androstener.
DK117955B (da) Analogifremgangsmåde til fremstilling af N&lt;4&gt;-acrylerede 1-halogenbenzen-2,4-disulfonamider.
DK113917B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetrachlorcyclohexanon.
DK109329C (da) Fremgangsmåde til fremstilling af Δ&lt;4&gt;-6α-alkyl-19-nor-pregnener.
DK108721C (da) Fremgangsmåde til fremstilling af 17&lt;IMAGE&gt;-ethoxy-6-chlor-6-dehydro-progesteron.
DK114552B (da) Fremgangsmåde til fremstilling af 1-metyl-Δ&lt;1&gt;-5α-androsten-17β-ol-3-on-17-estere.
DK114202B (da) Fremgangsmåde til fremstilling af 5β-H-6-keto-Δ&lt;7&gt;-14α-hydroksysteroider.
DK109639C (da) Fremgangsmåde til fremstilling af 3-oxo-17β-hydroxy-17α-methylestra-4,9,11-trien.
DK131669B (da) Fremgangsmåde til fremstilling af bicyclo/2,2,2/oct-2-ener.